Form 4 for NVDA Nvidia
Accepted 2025-06-27 18:15:26 ET · period of report 2025-06-25 · accession 0001045810-25-000151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2025-06-27 18:15 | 2025-06-25+ | NVDA | SEAWELL A BROOKE | Dir | S - Sale | $154.63 | -155.2K | 1.68M | -8% | -$24.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-25 | S | D | 6,892 | $149.97 | 1,827,678 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F2) Represents weighted average sales price. The shares were sold at prices ranging from $149.520 to $150.480. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 2 | Common | Common Stock | 2025-06-25 | S | D | 10,967 | $151.16 | 1,816,711 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F4) Represents weighted average sales price. The shares were sold at prices ranging from $150.500 to $151.490. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 3 | Common | Common Stock | 2025-06-25 | S | D | 28,055 | $151.89 | 1,788,656 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F5) Represents weighted average sales price. The shares were sold at prices ranging from $151.510 to $152.490. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 4 | Common | Common Stock | 2025-06-25 | S | D | 6,860 | $152.69 | 1,781,796 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F6) Represents weighted average sales price. The shares were sold at prices ranging from $152.495 to $152.980. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 5 | Common | Common Stock | 2025-06-26 | S | D | 13,561 | $154.69 | 1,768,235 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F7) Represents weighted average sales price. The shares were sold at prices ranging from $154.050 to $155.000. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 6 | Common | Common Stock | 2025-06-26 | S | D | 27,941 | $155.58 | 1,740,294 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F8) Represents weighted average sales price. The shares were sold at prices ranging from $155.040 to $156.000. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 7 | Common | Common Stock | 2025-06-26 | S | D | 9,953 | $156.25 | 1,730,341 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F9) Represents weighted average sales price. The shares were sold at prices ranging from $156.010 to $156.680. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 8 | Common | Common Stock | 2025-06-27 | S | D | 14,355 | $155.97 | 1,715,986 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F10) Represents weighted average sales price. The shares were sold at prices ranging from $155.280 to $156.270. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 9 | Common | Common Stock | 2025-06-27 | S | D | 18,411 | $156.74 | 1,697,575 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F11) Represents weighted average sales price. The shares were sold at prices ranging from $156.280 to $157.270. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 10 | Common | Common Stock | 2025-06-27 | S | D | 13,013 | $157.62 | 1,684,562 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F12) Represents weighted average sales price. The shares were sold at prices ranging from $157.275 to $158.260. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |
| 11 | Common | Common Stock | 2025-06-27 | S | D | 5,201 | $158.43 | 1,679,361 | I By Administrative Trust | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. (F13) Represents weighted average sales price. The shares were sold at prices ranging from $158.275 to $158.700. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. |